Daniel Laheru, MD

The Johns Hopkins Weinberg Outpatient Pharmacy located in The Sidney Kimmel Comprehensive Cancer Center (Ceremonial Lobby) values the patronage of both patients and employees. We strive to exceed all service expectations through the accurate, timely and professional provision of prescription services.

Nilofer Azad, MD, located in Baltimore, MD, is a distinguished medical practice renowned for its commitment to providing exceptional patient care and advancing medical knowledge through innovative research. With a focus on delivering comprehensive healthcare services, this esteemed facility offers a wide range of treatments, from routine medical care to specialized interventions. The team of medical professionals at Nilofer Azad, MD, works collaboratively to ensure the highest standards of care across various medical disciplines, including cardiology, neurology, oncology, and pediatrics. Emphasizing the importance of education and training, Nilofer Azad, MD, prepares the next generation of healthcare professionals to uphold the same level of excellence and dedication to scientific progress. By fostering a culture of continuous learning and research, this medical practice stands at the forefront of medical innovation, consistently striving to enhance patient outcomes and promote overall well-being. With a steadfast commitment to advancing healthcare through cutting-edge research and compassionate patient care, Nilofer Azad, MD, remains a trusted institution in the field of medicine. Generated using this brand's available information

As a member of the Johns Hopkins Kimmel Cancer Center, my group's research is focused on finding novel therapies for the treatment of both acute and chronic graft versus host disease (GVHD). To that end, we are developing new strategies for prophylaxis as well as therapies for this problem. We are exploring the use of drugs such as pentostatin in steroid refractory GVHD. This drug inhibits an enzyme, called ADA, that induces apoptosis (cell death) of lymphocytes, the effector cells in GVHD. Our results using this approach have been quite encouraging. Also, we are exploring other novel approaches such as extracorporeal photopheresis or high-dose cyclophosphamide. We are participating in the NIH Bone Marrow Transplant Clinical Trials Network consortium to find useful therapies for GVHD. We are also members of the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials on Chronic GVHD, and there we are trying to establish rational guidelines for supportive care, trial design, etc. We run an internationally unique GVHD multidisciplinary clinic with many GVHD experts including a nurse practitioner, research nurse and others from fields such as physical medicine and rehabilitation, gastroenterology, ophthalmology, dermatology, pulmonology and more.